DOCSLIB.ORG

Supplemental Information for Exposure Use Assessment Pbts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplemental Information for Exposure Use Assessment Pbts EPA Document # EPA-740-R1-8003 June 2018 United States Office of Chemical Safety and Environmental Protection Agency Pollution Prevention Supplemental Information for the Exposure and Use Assessment of Five Persistent, Bioaccumulative and Toxic Chemicals Peer Review Draft June 2018 Contents Appendix A. Supplemental Document for Decabromodiphenyl ethers (DecaBDE) ...................................................... 7 A.1 Literature Search Strategy ........................................................................................................................... 7 A.1.1. Database (Peer-reviewed) Search Strategies ...................................................................................... 8 A.1.2. Gray Literature Search Strategies ........................................................................................................ 9 A.1.3. Supplemental Search Strategy .......................................................................................................... 15 Backward Search ........................................................................................................................................... 15 Google Scholar Search ................................................................................................................................... 15 A.1.4. Literature Search Results ................................................................................................................... 15 A.2 Literature Screening Strategy ..................................................................................................................... 16 A.2.1. Development of the Literature Screening Approach ........................................................................ 16 A.2.2. Literature Screening Pilot .................................................................................................................. 17 A.2.3. Literature Screening .......................................................................................................................... 17 A.2.4. Prioritization ...................................................................................................................................... 18 A.3 PECO Statement ......................................................................................................................................... 20 A.4 PRISMA Diagram ........................................................................................................................................ 21 A.5 Data Evaluation Criteria ............................................................................................................................. 21 A.6 Data Extraction Fields ................................................................................................................................ 22 Appendix B. Supplemental Document for Hexachlorobutadiene (HCBD) Literature Search Strategy ........................ 23 B.1.1. Database (Peer-reviewed) Search Strategies .................................................................................... 23 B.1.2. Gray Literature Search Strategies ...................................................................................................... 24 B.1.3. Supplemental Search Strategy .......................................................................................................... 30 Backward Search ........................................................................................................................................... 30 Google Scholar Search ................................................................................................................................... 30 B.1.4. Literature Search Results ................................................................................................................... 30 B.2 Literature Screening Strategy ..................................................................................................................... 31 B.2.1. Development of the Literature Screening Approach ........................................................................ 31 B.2.2. Literature Screening Pilot .................................................................................................................. 31 B.2.3. Literature Screening .......................................................................................................................... 31 B.3 PECO Statement ......................................................................................................................................... 32 B.4 PRISMA Diagram ........................................................................................................................................ 33 B.5 Data Evaluation Criteria ............................................................................................................................. 33 B.6 Data Extraction Fields ................................................................................................................................ 34 Appendix C. Supplemental Document for Phenol, isopropylated, phosphate (3:1) (ITPP) ......................................... 35 C.1 Literature Search Strategy ......................................................................................................................... 35 Page 2 of 94 C.1.1. Database (Peer-reviewed) Search Strategies .................................................................................... 35 C.1.2. Gray Literature Search Strategies ...................................................................................................... 38 C.1.3. Supplemental Search Strategy .......................................................................................................... 44 Backward Search ........................................................................................................................................... 44 Google Scholar Search ................................................................................................................................... 44 C.1.4. Literature Search Results ................................................................................................................... 44 C.2 Literature Screening Strategy ..................................................................................................................... 45 C.2.1. Development of the Literature Screening Approach ........................................................................ 45 C.2.2. Literature Screening Pilot .................................................................................................................. 45 C.2.3. Literature Screening .......................................................................................................................... 45 C.2.4. Prioritization ...................................................................................................................................... 46 C.3 PECO Statement ......................................................................................................................................... 48 C.4 PRISMA Diagram ........................................................................................................................................ 49 C.5 Data Evaluation Criteria ............................................................................................................................. 49 C.6 Data Extraction Fields ................................................................................................................................ 50 Appendix D. Supplemental Document for 2,4,6-Tris(tert-butyl) phenol (TTBP).......................................................... 51 D.1 Literature Search Strategy ......................................................................................................................... 51 D.1.1. Database (Peer-reviewed) Search Strategies .................................................................................... 52 D.1.2. Gray Literature Search Strategies ...................................................................................................... 54 D.1.3. Supplemental Search Strategy .......................................................................................................... 60 Backward Search ........................................................................................................................................... 60 Google Scholar Search ................................................................................................................................... 60 D.1.4. Literature Search Results ................................................................................................................... 60 D.2 Literature Screening Strategy ..................................................................................................................... 61 D.2.1. Development of the Literature Screening Approach ........................................................................ 61 D.2.2. Literature Screening Pilot .................................................................................................................. 61 D.2.3. Literature Screening .......................................................................................................................... 62 D.2.4. Prioritization .....................................................................................................................................
Load more

Recommended publications
  • Phosphorus Oxychloride CAS No
    Product Safety Summary Phosphorus Oxychloride CAS No. 10025-87-3 This Product Safety Summary is intended to provide a general overview of the chemical substance. The information in the summary is basic information and is not intended to provide emergency response information, medical information or treatment information. The summary should not be used to provide in-depth safety and health information. In-depth safety and health information can be found in the Safety Data Sheet (SDS) for the chemical substance. Names Phosphorus oxychloride Phosphorus trichloride oxide Phosphoric trichloride POCl 3 Product Overview Solvay Novecare does not sell phosphorus oxychloride directly to consumers. Phosphorus oxychloride (POCl3) is used as a chemical intermediate to produce a variety of products which are used in several applications including manufacture of triarylphosphate esters which are used as flame retardants as well as an intermediate in the production of pharmaceutical, textile and agricultural chemicals. Phosphorus oxychloride is used in industrial applications and other processes where workplace exposures can occur. Consumer exposure does not occur as phosphorus oxychloride is not used in any commercially available product. Phosphorus oxychloride is dangerous to human health. Phosphorus oxychloride may be fatal if inhaled, highly toxic if swallowed, harmful if absorbed through skin and can cause severe burns which may result in scarring. Phosphorus oxychloride is consumed in manufacturing processes. POCl3 can make its way into the environment through unintentional releases (spills). POCl3 will not bioaccumulate but is not biodegradable. POCl3 in higher concentrations can be harmful to aquatic life due to formation of acids from the hydrolysis of POCl3. When released into the atmosphere, phosphorus oxychloride exists as vapor.
    [Show full text]
  • PUBLIC HEALTH STATEMENT Hexachlorobutadiene CAS#: 87-68-3
    PUBLIC HEALTH STATEMENT Hexachlorobutadiene CAS#: 87-68-3 Division of Toxicology May 1994 This Public Health Statement is the summary be exposed to a substance only when you come in chapter from the Toxicological Profile for contact with it. You may be exposed by breathing, Hexachlorobutadiene. It is one in a series of Public eating, or drinking substances containing the Health Statements about hazardous substances and substance or by skin contact with it. their health effects. A shorter version, the ToxFAQsTM is also available. This information is If you are exposed to a substance such as important because this substance may harm you. hexachlorobutadiene, many factors will determine The effects of exposure to any hazardous substance whether harmful health effects will occur and what depend on the dose, the duration, how you are the type and severity of those health effects will be. exposed, personal traits and habits, and whether These factors include the dose (how much), the other chemicals are present. For more information, duration (how long), the route or pathway by which call the ATSDR Information Center at 1-888-422- you are exposed (breathing, eating, drinking, or skin 8737. contact), the other chemicals to which you are _____________________________________ exposed, and your individual characteristics such as age, gender, nutritional status, family traits, life- This Statement was prepared to give you style, and state of health. information about hexachlorobutadiene and to emphasize the human health effects that may result 1.1 WHAT IS HEXACHLOROBUTADIENE? from exposure to it. The Environmental Protection Agency (EPA) has identified 1,350 hazardous waste Hexachlorobutadiene, also known as HCBD, sites as the most serious in the nation.
    [Show full text]
  • Draft Scope of the Risk Evaluation for Triphenyl Phosphate CASRN 115-86-6
    EPA Document# EPA-740-D-20-010 April 2020 United States Office of Chemical Safety and Environmental Protection Agency Pollution Prevention Draft Scope of the Risk Evaluation for Triphenyl Phosphate CASRN 115-86-6 April 2020 TABLE OF CONTENTS ACKNOWLEDGEMENTS ......................................................................................................................5 ABBREVIATIONS AND ACRONYMS ..................................................................................................6 EXECUTIVE SUMMARY .......................................................................................................................8 1 INTRODUCTION ............................................................................................................................11 2 SCOPE OF THE EVALUATION ...................................................................................................11 2.1 Reasonably Available Information ..............................................................................................11 Search of Gray Literature ...................................................................................................... 12 Search of Literature from Publicly Available Databases (Peer-Reviewed Literature) .......... 13 Search of TSCA Submissions ................................................................................................ 19 2.2 Conditions of Use ........................................................................................................................19 Categories
    [Show full text]
  • OFR Staff Plan
    Staff Briefing Package Project Plan: Organohalogen Flame Retardant Chemicals Assessment July 1, 2020 CPSC Consumer Hotline and General Information: 1-800-638-CPSC (2772) CPSC's Web Site: http://www.cpsc.gov THIS DOCUMENT HAS NOT BEEN REVIEWED CLEARED FOR PUBLIC RELEASE OR ACCEPTED BY THE COMMISSION UNDER CPSA 6(b)(1) Acknowledgments The preparation, writing, and review of this report was supported by a team of staff. We acknowledge and thank team members for their significant contributions. Michael Babich, Ph.D., Directorate for Health Sciences Charles Bevington, M.P.H., Directorate for Health Sciences Xinrong Chen, Ph.D., D.A.B.T., Directorate for Health Sciences Eric Hooker, M.S., D.A.B.T., Directorate for Health Sciences Cynthia Gillham, M.S., Directorate for Economic Analysis John Gordon, Ph.D., Directorate for Health Sciences Kristina Hatlelid, Ph.D., M.P.H., Directorate for Health Sciences Barbara Little, Attorney, Office of the General Counsel Joanna Matheson, Ph.D., Directorate for Health Sciences ii THIS DOCUMENT HAS NOT BEEN REVIEWED CLEARED FOR PUBLIC RELEASE OR ACCEPTED BY THE COMMISSION UNDER CPSA 6(b)(1) Table of Contents Briefing Memo ............................................................................................................................... iv 1. Executive summary .............................................................................................................. 5 2. Introduction .........................................................................................................................
    [Show full text]
  • Hexachlorobutadiene in Drinking-Water
    WHO/SDE/WSH/03.04/101 English only Hexachlorobutadiene in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality © World Health Organization 2004 Requests for permission to reproduce or translate WHO publications - whether for sale of for non- commercial distribution - should be addressed to Publications (Fax: +41 22 791 4806; e-mail: [email protected]. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damage incurred as a results of its use. Preface One of the primary goals of WHO and its member states is that “all people, whatever their stage of development and their social and economic conditions, have the right to have access to an adequate supply of safe drinking water.” A major WHO function to achieve such goals is the responsibility “to propose ... regulations, and to make recommendations with respect to international health matters ....” The first WHO document dealing specifically with public drinking-water quality was published in 1958 as International Standards for Drinking-water.
    [Show full text]
  • SDS) Is Provided for Compliance with Applicable Regulations of the Hazard Communication Standard of 2012 (HCS/HAZCOM 2012) Found in §29 CFR 1910.1200
    Safety Data Sheet Section 1 – Identification of the Mixture and of the Company Product Identification Primary Identifier(s) Used on the Label Berryman TRANSMISSION & POWER STEERING SEALER Product Synonym(s) blend “PSTS” Product Number(s) 0712 and 0755 Relevant Identified Uses and Uses Advised Against Recommended Uses automatic transmission and power steering pump seal conditioner Uses Advised Against not for use in manual transmissions Manufacturer/Supplier Details Berryman Products, Inc. 3800 E Randol Mill Rd Arlington, TX 76011 (800) 433-1704 (USA/Canada) (817) 640-2376 (international) www.BerrymanProducts.com Emergency 2424----HourHour Telephone Number(s) ––– InfoTrac, Inc. (800) 535-5053 (USA/Canada) (352) 323-3500 (international) Section 2 – Hazards Identification Classification of the Substance or Mixture (29 CFR 1910.1200) Physical Hazards Health Hazards Eye Irritant – Category 2B Specific Target Organ Toxicity - Repeated Exposure – Category 2 (blood/blood system) Environmental Hazard - Chronic – Category 1 Allocation of Label Elements Chemical Identity Berryman TRANSMISSION & POWER STEERING SEALER Pictograms Signal Word WARNING Hazard Statements H320 – Causes eye irritation. H373 – May cause damage to blood/blood system through prolonged or repeated exposure. H410 – Very toxic to aquatic life with long-lasting effects. Safety Data Sheet ––– Page 111 of 999 Berryman Products, Inc. ––– part #s 0712 and 0755 Prevention Precautionary Statements P101 – Keep out of reach of children. P102 – Read label before use. P260 – Do not breathe fumes, gas, mist, vapor, or spray. P264 – Wash thoroughly with soap and water after handling. P273 – Avoid release to the environment. Response Precautionary Statements P314 – Get medical advice/attention if you feel unwell. P391 – Collect spillage. P305/P351/P338 – IF IN EYES: Rinse cautiously with water for several minutes.
    [Show full text]
  • UNITED NATIONS Stockholm Convention on Persistent Organic
    UNITED NATIONS SC UNEP/POPS/POPRC.12/INF/12 Distr.: General 25 July 2016 English only Stockholm Convention on Persistent Organic Pollutants Persistent Organic Pollutants Review Committee Twelfth meeting Rome, 1923 September 2016 Item 4 (c) (ii) of the provisional agenda* Technical work: consideration of recommendations to the Conference of the Parties: unintentional releases of hexachlorobutadiene Draft evaluation of new information in relation to listing of hexachlorobutadiene in Annex C to the Stockholm Convention Note by the Secretariat As referred to in the note by the Secretariat on new information in relation to the listing of hexachlorobutadiene in Annex C to the Stockholm Convention (UNEP/POPS/POPRC.12/6), the annex to the present note sets out the draft evaluation of new information in relation to listing of hexachlorobutadiene in Annex C to the Stockholm Convention. The present note, including its annex, has not been formally edited. * UNEP/POPS/POPRC.12/1. 250716 UNEP/POPS/POPRC.12/INF/12 Annex Draft evaluation of new information in relation to the listing of hexachlorobutadiene in Annex C of the Stockholm Convention June 2016 2 UNEP/POPS/POPRC.12/INF/12 Table of Contents Executive summary .................................................................................................................................... 4 1. Introduction ..................................................................................................................................... 6 1.1 Overview ............................................................................................................................
    [Show full text]
  • In Vivo Characterisation of the Toxicological Properties of Dphp, One of the Main Degradation Product of Aryl Phosphate Esters
    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.26.888057; this version posted December 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. In vivo characterisation of the toxicological properties of DPhP, one of the main degradation product of aryl phosphate esters. Samia Ruby1*, Jesús Marín-Sáez2*, Aurélie Fildier3*, Audrey Buleté3, Myriam Abdallah1, Jessica Garcia4, Julie Deverchère1, Loïc Spinner3, Barbara Giroud3, Sébastien Ibanez5, Thierry Granjon5, Claire Bardel6,7, Béatrice Fervers1, Alain Puisieux1, Emmanuelle Vulliet3, Léa Payen1,4†, Arnaud M. Vigneron1† 1 Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Lé on Bé rard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France. 2 Department of Chemistry and Physics, Analytical Chemistry Area, University of Almería, Research Centre for Agricultural and Food Biotechnology (BITAL), Agrifood Campus of International Excellence ceiA3, Carretera de Sacramento s/n, E-04120 Almería, Spain 3 Université de Lyon, Institut des Sciences Analytiques, UMR 5280 CNRS, Université de Lyon, Université de Lyon 1, ENS-Lyon, 5 rue de la Doua, 69100 Villeurbanne, France 4 Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon–Sud, Biochemistry, pharmacotoxicology, and molecular biology department, Pierre Bénite, France 5Université de Lyon, Université Claude Bernard Lyon 1, CNRS, Molecular and Supramolecular Chemistry and Biochemistry Institute ICBMS UMR 5246, F-69622 Lyon, France 6 Department of biostatistics, Hospices Civils de Lyon, Lyon, France 7 Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, F- 69622 Villeurbanne, France *These authors contribute equally to this work † To whom correspondence should be addressed: Léa Payen- Arnaud M.
    [Show full text]
  • Health Effects Support Document for Hexachlorobutadiene Health Effects Support Document for Hexachlorobutadiene
    Health Effects Support Document for Hexachlorobutadiene Health Effects Support Document for Hexachlorobutadiene U.S. Environmental Protection Agency Office of Water (4304T) Health and Ecological Criteria Division Washington, DC 20460 www.epa.gov/safewater/ EPA 822-R-03-002 February 2003 Printed on Recycled Paper FOREWORD The Safe Drinking Water Act (SDWA), as amended in 1996, requires the Administrator of the Environmental Protection Agency (EPA) to establish a list of contaminants to aid the agency in regulatory priority setting for the drinking water program. In addition, SDWA requires EPA to make regulatory determinations for no fewer than five contaminants by August 2001. The criteria used to determine whether or not to regulate a chemical on the CCL are the following: The contaminant may have an adverse effect on the health of persons. The contaminant is known to occur or there is a substantial likelihood that the contaminant will occur in public water systems with a frequency and at levels of public health concern. In the sole judgment of the administrator, regulation of such contaminant presents a meaningful opportunity for health risk reduction for persons served by public water systems. The Agency’s findings for the three criteria are used in making a determination to regulate a contaminant. The Agency may determine that there is no need for regulation when a contaminant fails to meet one of the criteria. This document provides the health effects basis for the regulatory determination for hexachlorobutadiene. In arriving at the regulatory determination, data on toxicokinetics, human exposure, acute and chronic toxicity to animals and humans, epidemiology, and mechanisms of toxicity were evaluated.
    [Show full text]
  • Exposure and Use Assessment for Five PBT Chemicals
    EPA Document # EPA-740-R1-8002 June 2018 United States Office of Chemical Safety and Environmental Protection Agency Pollution Prevention Exposure and Use Assessment of Five Persistent, Bioaccumulative and Toxic Chemicals Peer Review Draft June 2018 Contents TABLES ................................................................................................................................................................... 7 FIGURES ................................................................................................................................................................. 7 1. EXECUTIVE SUMMARY ................................................................................................................................ 15 2. BACKGROUND ............................................................................................................................................. 15 3. APPROACH .................................................................................................................................................. 17 4. DECABROMODIPHENYL ETHER (DECABDE) .................................................................................................. 21 4.1. Chemistry and Physical-Chemical Properties ................................................................................ 21 4.2. Uses ................................................................................................................................................ 21 4.3. Characterization of Expected Environmental Partitioning
    [Show full text]
  • Hexachlorobutadiene
    UNITED NATIONS SC UNEP/POPS/POPRC.8/3 Distr.: General 11 July 2012 Original: English Stockholm Convention on Persistent Organic Pollutants Persistent Organic Pollutants Review Committee Eighth meeting Geneva, 15–19 October 2012 Item 4 (b) of the provisional agenda* Consideration of draft risk profiles: hexachlorobutadiene Draft risk profile: hexachlorobutadiene Note by the Secretariat 1. At its seventh meeting, the Persistent Organic Pollutants Review Committee adopted decision POPRC-7/3 on hexachlorobutadiene.1 By paragraph 2 of that decision, the Committee decided to establish an ad hoc working group to review further the proposal to list hexachlorobutadiene in Annexes A, B, and/or C to the Stockholm Convention on Persistent Organic Pollutants2 and to develop a draft risk profile in accordance with Annex E to the Convention. 2. A workplan for the preparation of draft risk profiles was adopted by the Committee at the same meeting.3 3. In accordance with decision POPRC-7/3 and the workplan, the ad hoc working group prepared the draft risk profile set out in the annex to the present note; it has not been formally edited by the Secretariat. Comments and responses relating to the draft risk profile are set out in document UNEP/POPS/POPRC.8/INF/5. Possible action by the Committee 4. The Committee may wish: (a) To adopt, with any amendments that it deems appropriate, the draft risk profile set out in the annex to the present note; (b) To decide, in accordance with paragraph 7 of Article 8 of the Convention and on the basis of the risk profile,
    [Show full text]
  • Hexachlorobutadiene – Sources, Environmental Fate and Risk Characterisation
    SCIENCE DOSSIER Hexachlorobutadiene – Sources, environmental fate and risk characterisation Professor André Lecloux October 2004 October 2004 This publication is the fifth in a series of Science Dossiers providing the scientific community with reliable information on selected issues. If you require more copies, please send an email indicating name and mailing address to [email protected]. The document is also available as a PDF file on www.eurochlor.org Science Dossiers published in this series: 1. Trichloroacetic acid in the environment (March 2002) 2. Chloroform in the environment: Occurrence, sources, sinks and effects (May 2002) 3. Dioxins and furans in the environment (January 2003) 4. How chlorine in molecules affects biological activity (November 2003) 5. Hexachlorobutadiene – sources, environmental fate and risk characterisation (October 2004) Copyright & Reproduction The copyright in this publication belongs to Euro Chlor. No part of this publication may be stored in a retrieval system or transmitted in any form or by any means, electronic or mechanical, including photocopying or recording, or otherwise, without the permission of Euro Chlor. Notwithstanding these limitations, an extract may be freely quoted by authors in other publications subject to the source being acknowledged with inclusion of a suitable credit line or reference to the original publication. Table of Contents Foreword ............................................................................................................................................
    [Show full text]